Other languages Ekso Bionics Holdings, Inc.

Equities

EKSO

US2826443010

Market Closed - Nasdaq Other stock markets 21:00:00 01/05/2024 BST			5-day change	1st Jan Change
1.275 ^USD	+2.82%		+8.05%	-49.00%

04-29	Transcript : Ekso Bionics Holdings, Inc., Q1 2024 Earnings Call, Apr 29, 2024
04-29	Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-04
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-04
Ekso Bionics Holdings, Inc. Launches GaitCoach Software for EksoNR	01-08
Ekso Bionics Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023	01-04
Ekso Bionics Holdings, Inc. Receives CMS Coding Approval for Ekso Indego Personal	12-12
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/10/23
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	27/07/23
Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Ekso Bionics Holdings, Inc. Announces Resignation of Stanley Stern from the Board, Effective on April 26, 2023	26/04/23
Ekso Bionics Holdings, Inc Announces Director Changes	09/12/22
Ekso Bionics Buys Parker Hannifin's Human Motion, Control Business for $10 Million; Names Davis CEO	05/12/22
Ekso Bionics Holdings, Inc. acquired Human Motion and Control Business Unit of Parker Hannifin Corporation for $10 million.	04/12/22
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	03/11/22
Ekso Bionics Holdings, Inc. Approves Appointment of Jerome Wong as Corporate Secretary and Principal Financial Officer	31/10/22
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	28/07/22
Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Posts Q2 Revenue $3.5M	28/07/22
Sector Update: Health Care Stocks Remain Lower Ahead of Market Close Monday	13/06/22
Sector Update: Health Care Stocks Fall in Early Monday Afternoon Trading	13/06/22
Ekso Bionics FDA-Cleared to Market Robotic Exoskeleton for Multiple Sclerosis; Shares Rise	13/06/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Ekso Bionics Holdings, Inc.

Equities

EKSO

US2826443010

Other languages

Filters